372 related articles for article (PubMed ID: 33690218)
21. Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses.
Parker L; Wharton SA; Martin SR; Cross K; Lin Y; Liu Y; Feizi T; Daniels RS; McCauley JW
J Gen Virol; 2016 Jun; 97(6):1333-1344. PubMed ID: 26974849
[TBL] [Abstract][Full Text] [Related]
22. Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Postvaccination Sera.
Xie H; Li L; Ye Z; Li X; Plant EP; Zoueva O; Zhao Y; Jing X; Lin Z; Kawano T; Chiang MJ; Finch CL; Kosikova M; Zhang A; Zhu Y; Wan XF
Clin Infect Dis; 2017 Jul; 65(2):259-267. PubMed ID: 28369230
[TBL] [Abstract][Full Text] [Related]
23. Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets.
Houser KV; Pearce MB; Katz JM; Tumpey TM
J Virol; 2013 Dec; 87(24):13480-9. PubMed ID: 24089569
[TBL] [Abstract][Full Text] [Related]
24. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
[TBL] [Abstract][Full Text] [Related]
25. Influenza Vaccine-Induced Antibody Responses Are Not Impaired by Frailty in the Community-Dwelling Elderly With Natural Influenza Exposure.
Narang V; Lu Y; Tan C; Camous XFN; Nyunt SZ; Carre C; Mok EWH; Wong G; Maurer-Stroh S; Abel B; Burdin N; Poidinger M; Tambyah PA; Bosco N; Visan L; Ng TP; Larbi A
Front Immunol; 2018; 9():2465. PubMed ID: 30405641
[No Abstract] [Full Text] [Related]
26. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
[TBL] [Abstract][Full Text] [Related]
27. Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans.
Khurana S; Hahn M; Coyle EM; King LR; Lin TL; Treanor J; Sant A; Golding H
Nat Commun; 2019 Jul; 10(1):3338. PubMed ID: 31350391
[TBL] [Abstract][Full Text] [Related]
28. Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.
Flannery B; Zimmerman RK; Gubareva LV; Garten RJ; Chung JR; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Ohmit SE; Belongia EA; McLean HQ; Gaglani M; Piedra PA; Mishin VP; Chesnokov AP; Spencer S; Thaker SN; Barnes JR; Foust A; Sessions W; Xu X; Katz J; Fry AM
J Infect Dis; 2016 Oct; 214(7):1010-9. PubMed ID: 27190176
[TBL] [Abstract][Full Text] [Related]
29. Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strain.
Mendelman PM; Rappaport R; Cho I; Block S; Gruber W; August M; Dawson D; Cordova J; Kemble G; Mahmood K; Palladino G; Lee MS; Razmpour A; Stoddard J; Forrest BD
Pediatr Infect Dis J; 2004 Nov; 23(11):1053-5. PubMed ID: 15545863
[TBL] [Abstract][Full Text] [Related]
30. A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine influenza viruses.
Rodriguez L; Nogales A; Murcia PR; Parrish CR; Martínez-Sobrido L
Vaccine; 2017 Aug; 35(34):4374-4381. PubMed ID: 28709557
[TBL] [Abstract][Full Text] [Related]
31. Antibody Landscape Analysis following Influenza Vaccination and Natural Infection in Humans with a High-Throughput Multiplex Influenza Antibody Detection Assay.
Li ZN; Liu F; Gross FL; Kim L; Ferdinands J; Carney P; Chang J; Stevens J; Tumpey T; Levine MZ
mBio; 2021 Feb; 12(1):. PubMed ID: 33531397
[TBL] [Abstract][Full Text] [Related]
32. Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013-2014 Through 2015-2016.
McLean HQ; King JP; Talley P; Flannery B; Spencer S; Levine MZ; Friedrich TC; Belongia EA
J Pediatric Infect Dis Soc; 2020 Apr; 9(2):173-180. PubMed ID: 30759228
[TBL] [Abstract][Full Text] [Related]
33. Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012-2013.
Cobey S; Gouma S; Parkhouse K; Chambers BS; Ertl HC; Schmader KE; Halpin RA; Lin X; Stockwell TB; Das SR; Landon E; Tesic V; Youngster I; Pinsky BA; Wentworth DE; Hensley SE; Grad YH
Clin Infect Dis; 2018 Jul; 67(3):327-333. PubMed ID: 29471464
[TBL] [Abstract][Full Text] [Related]
34. Influenza vaccination in the elderly boosts antibodies against conserved viral proteins and egg-produced glycans.
Jung J; Mundle ST; Ustyugova IV; Horton AP; Boutz DR; Pougatcheva S; Prabakaran P; McDaniel JR; King GR; Park D; Person MD; Ye C; Tan B; Tanno Y; Kim JE; Curtis NC; DiNapoli J; Delagrave S; Ross TM; Ippolito GC; Kleanthous H; Lee J; Georgiou G
J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34196304
[TBL] [Abstract][Full Text] [Related]
35. Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection.
DeDiego ML; Anderson CS; Yang H; Holden-Wiltse J; Fitzgerald T; Treanor JJ; Topham DJ
Immunology; 2016 Jun; 148(2):160-73. PubMed ID: 26854888
[TBL] [Abstract][Full Text] [Related]
36. In-depth phylogenetic analysis of the hemagglutinin gene of influenza A(H3N2) viruses circulating during the 2016-2017 season revealed egg-adaptive mutations of vaccine strains.
Galli C; Orsi A; Pariani E; Lai PL; Guarona G; Pellegrinelli L; Ebranati E; Icardi G; Panatto D
Expert Rev Vaccines; 2020 Jan; 19(1):115-122. PubMed ID: 31875483
[No Abstract] [Full Text] [Related]
37. Impact of Immune Priming, Vaccination, and Infection on Influenza A(H3N2) Antibody Landscapes in Children.
Hinojosa M; Shepard SS; Chung JR; King JP; McLean HQ; Flannery B; Belongia EA; Levine MZ
J Infect Dis; 2021 Aug; 224(3):469-480. PubMed ID: 33090202
[TBL] [Abstract][Full Text] [Related]
38. Immunological persistence of a seasonal influenza vaccine in people more than 3 years old.
Bai Y; Shi N; Lu Q; Yang L; Wang Z; Li L; Han H; Zheng D; Luo F; Zhang Z; Ai X
Hum Vaccin Immunother; 2015; 11(7):1648-53. PubMed ID: 26083828
[TBL] [Abstract][Full Text] [Related]
39. Intanza(®) 15 mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses.
Ansaldi F; Canepa P; Ceravolo A; Valle L; de Florentiis D; Oomen R; Vogel FR; Denis M; Samson SI; Icardi G
Vaccine; 2012 Apr; 30(18):2908-13. PubMed ID: 22342501
[TBL] [Abstract][Full Text] [Related]
40. Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV).
Skowronski DM; Sabaiduc S; Leir S; Rose C; Zou M; Murti M; Dickinson JA; Olsha R; Gubbay JB; Croxen MA; Charest H; Bastien N; Li Y; Jassem A; Krajden M; De Serres G
Euro Surveill; 2019 Nov; 24(46):. PubMed ID: 31771709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
